According to the latest report by GMI Research, Precision Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2020-2027. The Global Precision Medicine Market examines the impact of the COVID-19 pandemic and represents that the market is likely to experience a slump in 2020 and will surge in 2021 while growing at a higher rate from 2022 onwards. Precision medicine, also known as personalized medicine, is an approach to tackle diseases that have eluded effective treatments or cures. In precision medicine, diagnostic testing is often used to select appropriate therapies based on the patient’s genetic content or other analysis.

Competitive Landscape: The Global Precision Medicine Market report also scans the competitive landscape and profiles the major players operating in the market, including GE Healthcare, bioMerieux SA, IBM Corporation, Illumina, Inc., Novartis AG, Roche Group, and Abbott Laboratories.

Request for a free sample report copy: https://www.gmiresearch.com/report/global-precision-medicine-market/sample-request

Precision medicine market is gaining momentum over the past few years, with the precision medicine market growth likely to continue due to the novel approach of treatment it offers. The global precision medicine market is being eyed upon as lucrative business investment opportunity by the leading pharmaceutical organization owing to the increasing number of patient’s preference for personalized treatment, advancements in wireless technologies and big data analytics, and the drastic rise in genetic diseases such as cancer. Moreover, the rapid increase in the research activities related to precision medicine over the past few years is responsible for the expansion in the precision medicine market size.

Favorable government initiatives will positively influence the precision medicine market growth. For example, the UK government has invested USD 212.8 million for developing technologically advanced infrastructure to manufacture innovative medicine, including precision medicine through its Industrial Strategy Challenge Fund, initiated in December 2017.

For further information on these analyses, please visit: https://www.gmiresearch.com/report/global-precision-medicine-market/

Market Segments:

Breakup by Technology:

Big Data Analytics
Gene Sequencing
Companion Diagnostics
Drug Discovery
Bioinformatics
Breakup by Application:

Oncology
Neurology
Immunology
Respiratory
Hematology
Others
Breakup by Region:

North America
o United States of America

o Canada

Asia Pacific
o China

o Japan

o India

o Rest of APAC

Europe
o United Kingdom

o Germany

o France

o Spain

o Rest of Europe

RoW
o Brazil

o South Africa

o Saudi Arabia

o UAE

o Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is a market research and consulting firm which provides bespoke industry & market research to help businesses in making the toughest business decision. We know the significance of accurate data; that’s why our analyst use tailored methodology to study every market in detail because one size doesn’t fit all. We not only cover the traditional well-established market but also focuses on niche market and markets in the emerging economies, where getting data and information is a challenge. This factor makes us pioneer in emerging market research space. Our syndicate reports cover multiple industries across various regions and countries.

Our in-depth market reports help propel your business with all the data, strategic inputs, and competitive intelligence to move ahead even in the most uncertain times. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research look forward to help businesses stay ahead of the curve.